Investors bought shares of Johnson & Johnson (NYSE:JNJ) on weakness during trading hours on Friday. $178.45 million flowed into the stock on the tick-up and $65.26 million flowed out of the stock on the tick-down, for a money net flow of $113.19 million into the stock. Of all companies tracked, Johnson & Johnson had the highest net in-flow for the day. Johnson & Johnson traded down ($0.55) for the day and closed at $123.22

A number of equities research analysts have recently issued reports on the stock. BTIG Research lowered shares of Johnson & Johnson from a “buy” rating to a “neutral” rating in a report on Thursday, May 12th. Piper Jaffray Cos. upped their target price on shares of Johnson & Johnson from $105.00 to $106.00 and gave the stock a “neutral” rating in a report on Wednesday, April 20th. Morgan Stanley reaffirmed a “hold” rating on shares of Johnson & Johnson in a report on Thursday, May 19th. Wells Fargo & Co. reaffirmed a “buy” rating on shares of Johnson & Johnson in a report on Monday, July 11th. Finally, JPMorgan Chase & Co. reaffirmed a “hold” rating on shares of Johnson & Johnson in a report on Sunday, April 17th. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $119.30.

The firm has a 50 day moving average price of $123.01 and a 200-day moving average price of $113.08. The stock has a market cap of $337.11 billion and a PE ratio of 22.96.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.68 by $0.06. The company had revenue of $18.50 billion for the quarter, compared to analysts’ expectations of $17.98 billion. Equities research analysts predict that Johnson & Johnson will post $6.69 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 19th. Investors of record on Friday, August 5th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 0.94%.

In other Johnson & Johnson news, VP Dominic J. Caruso sold 41,146 shares of Johnson & Johnson stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $125.01, for a total value of $5,143,661.46. Following the completion of the sale, the vice president now owns 157,819 shares in the company, valued at approximately $19,728,953.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Ronald A. Kapusta sold 2,935 shares of Johnson & Johnson stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $125.01, for a total value of $366,904.35. Following the completion of the sale, the chief accounting officer now owns 28,660 shares of the company’s stock, valued at approximately $3,582,786.60. The disclosure for this sale can be found here.

Other hedge funds have bought and sold shares of the company. World Asset Management Inc boosted its stake in Johnson & Johnson by 3.5% in the fourth quarter. World Asset Management Inc now owns 307,991 shares of the company’s stock valued at $31,637,000 after buying an additional 10,434 shares during the period. San Francisco Sentry Investment Group CA boosted its stake in Johnson & Johnson by 4.8% in the fourth quarter. San Francisco Sentry Investment Group CA now owns 18,551 shares of the company’s stock valued at $1,906,000 after buying an additional 842 shares during the period. Transamerica Financial Advisors Inc. boosted its stake in Johnson & Johnson by 6.6% in the fourth quarter. Transamerica Financial Advisors Inc. now owns 41,860 shares of the company’s stock valued at $4,300,000 after buying an additional 2,603 shares during the period. WealthTrust Fairport LLC boosted its stake in Johnson & Johnson by 3.7% in the fourth quarter. WealthTrust Fairport LLC now owns 20,680 shares of the company’s stock valued at $2,124,000 after buying an additional 746 shares during the period. Finally, Sheets Smith Wealth Management boosted its stake in Johnson & Johnson by 0.3% in the fourth quarter. Sheets Smith Wealth Management now owns 14,844 shares of the company’s stock valued at $1,525,000 after buying an additional 45 shares during the period.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.